Apotheke zur Kaiserkrone
Austria · owned by Mag. pharm. Dr. Andrea Exner e.U. (Austria) · apotheke.at · 22 vendors
Apotheke zur Kaiserkrone is an Austrian pharmacy (Apotheke) based in Vienna. The company operates the website apotheke.at, offering a range of pharmaceutical products, medical devices, and health-related items. It functions as a traditional local pharmacy while also providing an online platform for customers to order medications and other healthcare products.
Resilience scores
- Digital Sovereignty: 9
- Digital Resilience: 4
Technology vendors
- Meta Platforms, Inc. — Technology — United States
- Shopware — Technology — Germany
- Stripe, Inc. — Financial Services — United States
- and 19 more
Insights
Last updated 2026-01-19 · revision 14
22 direct vendors, 250 subvendors
Direct vendors by controlling owner country (sample)
- Australia: 1
- United States: 11
- Austria: 2
Subvendors by controlling owner country (sample)
- Austria: 1
- United States: 174
- Sweden: 5
Migration Readiness: 3/10
Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.
Apotheke zur Kaiserkrone demonstrates low migration readiness, primarily due to a combination of an undefined tech stack, stringent regulatory and data residency requirements, and the inherent complexity of its service landscape. The 'Internal Tech Stack' is empty, and 'Key Technologies' (E-commerce Platform, Pharmacy Management System, Online Ordering System) do not indicate modern, cloud-native, or microservices architectures. This suggests a likely reliance on legacy or monolithic systems, which are typically complex, costly, and time-consuming to migrate to new environments. The regulatory environment poses significant challenges. GDPR, NIS2, the Austrian Medicines Act, and the Austrian Pharmacy Act all require 'Assessment' and carry 'High' or 'Medium' risk levels. These regulations impose strict requirements on data handling, security, and operational continuity, which must be meticulously addressed throughout any migration process, adding considerable complexity and potential delays. Furthermore, data residency requirements are particularly strict for an Austrian pharmacy handling sensitive health data. GDPR mandates EEA processing for EU resident data, with additional potential restrictions from Austrian national law for local storage of prescription and patient records. This severely limits the choice of cloud providers and dictates complex data architecture and transfer strategies. The company utilizes 52 services. While the geographic diversity of vendor HQ countries (7 unique countries) might suggest less lock-in to a single vendor ecosystem, the sheer number of services implies a substantial effort in terms of planning, execution, and integration during a migration. The 'Vendor Lock-in Risk' is unknown, which is a neutral factor. Financial stability for funding a major migration is also uncertain, given the lack of growth history and high revenue concentration. These factors collectively indicate that a migration would be a highly complex, resource-intensive, and risky undertaking for Apotheke zur Kaiserkrone.
Compliance
5 in-scope frameworks identified; showing 3.
ISO 27001 (source) — Assessment Required
Voluntary but recommended for organizations handling sensitive data, valuable for pharmacies processing health data to reduce cybersecurity risks.
ISO 27001 is not mandatory but recommended for organizations handling sensitive data. For pharmacies processing health data, implementing ISO 27001 reduces cybersecurity risks and demonstrates due diligence. Risk is medium because while not legally required, it's increasingly expected in healthcare sectors and can impact business relationships and insurance coverage.
GDPR (source) — Assessment Required
Mandatory for all EU-based companies processing personal data, especially sensitive health data as an Austrian pharmacy.
GDPR is mandatory for all EU-based companies processing personal data. As an Austrian pharmacy, Apotheke zur Kaiserkrone processes patient data, employee data, and customer information, making GDPR compliance critical. Non-compliance can result in fines up to 4% of annual turnover or €20 million. The healthcare sector faces heightened scrutiny due to sensitive personal data processing.
Austrian Pharmacy Act — Assessment Required
Fundamental legislation governing pharmacy establishment, operation, and professional practice in Austria.
The Austrian Pharmacy Act is fundamental legislation governing pharmacy establishment, operation, and professional practice. Non-compliance can result in license suspension or revocation, making this a high-risk regulatory requirement that directly impacts business continuity.
Financials
Three-year financials
- null:
- null:
- null:
Financial Resilience Score: null/10
While a quantitative score cannot be calculated without financial statements, a qualitative assessment suggests a high degree of resilience. Pharmacies provide essential healthcare products and services. Demand for medicine is non-cyclical and inelastic, meaning it remains stable even during economic downturns. This provides a foundational layer of revenue stability. The name "zur Kaiserkrone" suggests a long-standing, traditional pharmacy with a strong local reputation and a loyal customer base. The operation of a professional e-commerce website (apotheke.at) demonstrates adaptation to modern consumer behavior. This diversifies its revenue stream beyond local foot traffic and expands its market reach across Austria, mitigating risks associated with purely local economic or demographic shifts. The Austrian pharmaceutical market is highly regulated, which creates high barriers to entry for new competitors, protecting the market position of established pharmacies.
Key strengths: Essential Service Provider, Established Presence, Modernized Business Model, Regulatory Environment
Risk factors: Increased competition from large pharmacy chains or major online-only retailers, Potential government reforms to drug pricing and reimbursement policies
Revenue by geography
- Austria: 100%
Revenue by product/service
- Prescription Medications (Rx): 65%
- Over-the-Counter (OTC) Products: 15%
- Other Goods: 10%
- Personal Care & Cosmetics: 10%
Workforce by country
- Austria: 0
- Other Countries: 0
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.